SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting
Greystoke, Alastair, Steele, Nicola, Arkenau, Hendrik-Tobias, Blackhall, Fiona, Md Haris, Noor, Lindsay, Colin R, Califano, Raffaele, Voskoboynik, Mark, Summers, Yvonne, So, Karen, Ghiorghiu, Dana, DyLangue:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2017.271
Date:
August, 2017
Fichier:
PDF, 472 KB
english, 2017
File converter
Plus de résultats de recherche
More benefits 
